Marico Limited Allots 17,077 Equity Shares Under ESOP 2016, Increases Paid-Up Share Capital

1 min read     Updated on 24 Feb 2026, 10:27 AM
scanx
Reviewed by
Naman SScanX News Team
Overview

Marico Limited allotted 17,077 equity shares under ESOP 2016 on February 24, 2026, increasing paid-up share capital from Rs. 1,29,81,18,654 to Rs. 1,29,81,35,731. The shares were issued across four tranches with exercise prices ranging from Re. 1 to Rs. 506.17 per share. All newly allotted shares rank pari-passu with existing equity shares and carry no lock-in restrictions.

33454661

*this image is generated using AI for illustrative purposes only.

Marico Limited has allotted 17,077 equity shares under its Employee Stock Option Plan 2016 (ESOP 2016) to eligible employees on February 24, 2026. The Securities Committee of the Board of Directors approved the allotment through a resolution passed on the same date, following the exercise of stock options by eligible grantees.

Share Capital Enhancement

The allotment resulted in an increase in the company's paid-up share capital, as detailed below:

Parameter: Before Allotment After Allotment
Number of Shares: 1,29,81,18,654 equity shares 1,29,81,35,731 equity shares
Share Capital Value: Rs. 1,29,81,18,654 Rs. 1,29,81,35,731
Face Value per Share: Re. 1 each Re. 1 each

Allotment Details Across Multiple Tranches

The 17,077 equity shares were issued across four separate tranches under the ESOP 2016 scheme:

Tranche: Shares Issued Exercise Price per Share Premium per Share
Annexure I: 3,234 Re. 1 Nil
Annexure II: 7,160 Rs. 372.10 Rs. 371.10
Annexure III: 5,683 Rs. 498.25 Rs. 497.25
Annexure IV: 1,000 Rs. 506.17 Rs. 505.17

Regulatory Compliance and Share Characteristics

The allotment was conducted in compliance with Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The company clarified that this allotment is not material in nature. All newly issued equity shares carry the same rights and privileges as existing shares, ranking pari-passu with the company's current equity shares.

Administrative Details

The shares were issued in dematerialized form under ISIN number INE196A01026. No lock-in period applies to these shares, and no listing fees are payable for this allotment. The company has informed both BSE Limited and National Stock Exchange of India Limited about this development, where Marico's shares are listed.

Company Secretary and Compliance Officer Vinay M A signed the regulatory filings, confirming the completion of all necessary procedures for the share allotment under the established employee stock option framework.

Historical Stock Returns for Marico

1 Day5 Days1 Month6 Months1 Year5 Years
+1.10%+4.84%+9.35%+10.89%+30.42%+91.96%

Marico Limited Publishes Official Transcript of Strategic Investment Conference Call

3 min read     Updated on 13 Feb 2026, 03:21 PM
scanx
Reviewed by
Suketu GScanX News Team
Overview

Marico Limited has officially published the transcript of its strategic investment conference call held on February 13, 2026, filing it with BSE and NSE under Regulation 30. The comprehensive document outlines the company's transformation into a digital-first consumer powerhouse through strategic acquisitions including 4700BC, Cosmix, and Candid, with management projecting 3x-3.5x growth for these brands by FY30 and targeting ₹4,000 crore in total digital brands revenue globally.

32521897

*this image is generated using AI for illustrative purposes only.

Marico Limited has published the official transcript of its investor and analyst conference call held on February 13, 2026, following regulatory filing requirements. The company submitted the transcript to BSE Limited and National Stock Exchange of India Limited on February 18, 2026, providing comprehensive details of its digital transformation strategy and recent strategic acquisitions.

Regulatory Filing and Transparency

The company filed the transcript under Regulation 30, demonstrating its commitment to transparency with stakeholders. The document is available on the company's official website, ensuring broad accessibility for investors and analysts interested in understanding Marico's strategic direction.

Filing Details Information
Conference Date February 13, 2026
Filing Date February 18, 2026
BSE Scrip Code 531642
NSE Symbol MARICO
Regulation 30

Strategic Framework and Digital Transformation

During the conference call, MD & CEO Saugata Gupta outlined Marico's transformation from a legacy FMCG incumbent to a digital-first consumer powerhouse. The strategy rests on five strategic pillars: evidence-backed acquisitions, operational discipline with healthy unit economics, synergy acceleration through distribution integration, prudent capital allocation, and a repeatable playbook with time-tested operating models.

The company's digital portfolio spans three strategic domains: digital foods, digital personal care, and global digital brands. This comprehensive approach positions Marico to capture opportunities across India and Vietnam's rapidly evolving digital consumer landscape.

Recent Strategic Acquisitions Performance

4700BC Gourmet Snacks

4700BC operates with an annual run rate of ₹140 crore and has achieved significant market penetration with over 6 crore units sold annually. The brand maintains a 60% Net Promoter Score as the #2 player in the popcorn category.

4700BC Metrics Performance
Annual Run Rate ₹140 Cr
Units Sold 6 Cr+ annually
Net Promoter Score 60%
Market Position #2 in Popcorn
Revenue Mix - Popcorn ~75%
Revenue Mix - Other Snacks ~25%

Cosmix Plant Protein Platform

Cosmix demonstrates strong fundamentals with an annual run rate of ₹100 crore and over 2 lakh active customers. The brand maintains high teen sustainable EBITDA margins while achieving #1 bestseller status on leading e-commerce and quick commerce platforms.

Cosmix Parameters Details
Annual Run Rate ₹100 Cr
Active Customer Base 2 Lakh+
EBITDA Margins High Teen
Product Mix - Protein Powders 95%
Product Mix - Supplements 5%

Candid Vietnam Success

Candid showcases Marico's international expansion capabilities with approximately ₹100 crore revenue in CY2025 and sustainable EBITDA margins exceeding 25%. The brand operates in the mid-premium segment with strategic price positioning.

Candid Indicators Value
CY2025 Revenue ~₹100 Cr
EBITDA Margin 25%+
Price Range per SKU $30-55
Top 3 SKUs Revenue ~90%
E-commerce Share 55%
Influencer Partnerships 32%

Growth Projections and Strategic Outlook

Management outlined ambitious yet disciplined growth targets for the acquired brands. Each acquisition is projected to achieve 3x to 3.5x revenue growth by FY30 through category expansion and operational synergies. The company expects digital-first personal and consumer care annual recurring revenue to grow 5x from FY24 levels, while foods revenue is targeted to reach 15x growth from FY20 baseline.

FY30 Growth Targets Projection
Digital-first PPC ARR 5x from FY24
Foods Revenue Growth 15x from FY20
Combined Portfolio Share 33% of India Revenue
Total Digital Brands Revenue ₹4,000 Cr globally

Management Commentary and Strategic Vision

Saugata Gupta emphasized the company's disciplined approach to acquisitions, focusing on brands with proven product-market fit and healthy unit economics. The management highlighted successful scale-up examples including Beardo's 5x growth post-acquisition and Plix's 6x expansion in two years, validating the company's synergy-driven acquisition model.

Group CFO Pawan Agrawal reinforced the company's commitment to profitable growth, noting that recent acquisitions are expected to achieve EBITDA positivity within 12-18 months while maintaining disciplined capital allocation principles.

Historical Stock Returns for Marico

1 Day5 Days1 Month6 Months1 Year5 Years
+1.10%+4.84%+9.35%+10.89%+30.42%+91.96%

More News on Marico

1 Year Returns:+30.42%